Are you Dr. Schilsky?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 88 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
180 Harvester Dr
Ste 110
Burr Ridge, IL 60527Phone+1 773-834-4064
Summary
- Dr. Richard Schilsky, MD is an oncologist in Burr Ridge, Illinois. He is currently licensed to practice medicine in Illinois and Missouri. He is a Professor of Medicine at University of Chicago Medicine.
Education & Training
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1975 - 1977
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1975
Certifications & Licensure
IL State Medical License 1984 - 2023
MO State Medical License Active through 2013- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow (FASCO) American Society of Clinical Oncologists, 2012
- Super Doctor SuperDoctors.com
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer Start of enrollment: 2008 Apr 01
- Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement Start of enrollment: 2009 Mar 01
Publications & Presentations
PubMed
- Health Data Sharing Perspectives of Patients Receiving Care in CancerLinQ-Participating Oncology Practices.Reshma Jagsi, Krithika Suresh, Chris D Krenz, Rochelle D Jones, Kent A Griffith
JCO Oncology Practice. 2023-08-01 - 9 citationsClosing the Gap in Cancer Genomic Testing.Richard L Schilsky, Dan L Longo
The New England Journal of Medicine. 2022-12-08 - 1 citationsBeyond the COVID-19 Pandemic: Sustaining and Improving Equitable Cancer Care and Research.Richard L Schilsky
Cancer Journal. 2022-03-25
Press Mentions
KCA Brings Early-Career Clinicians Together for New Mentorship ProgramNovember 14th, 2024- ASCO Annual Meeting Returns to Chicago, Celebrates New Progress in CancerJune 15th, 2022
- The Evolution of NCI’s National Clinical Trials NetworkNovember 1st, 2021
- Join now to see all
Grant Support
- Cancer And Leukemia Group BNational Cancer Institute1995–2010
- Cancer And Leukemia Group B Human Specimen RepositoriesNational Cancer Institute2005–2009
- Cancer And Leukemia Group BNational Cancer Institute1995–2009
- Calgb - Foreign AccrualNational Cancer Institute2005
- Calgb Foreign AccrualNational Cancer Institute2003–2004
- Calgb Studies Of Breast Cancer In The ElderlyNational Cancer Institute2000–2004
- Cancer And Leukemia Group B CCOP Research BaseNational Cancer Institute1999–2003
- Phase I Study Of O-6 Benzylguanine And Carmustine In Advanced CancerNational Center For Research Resources1996–2002
- Core--Protocol Specific Research SupportNational Cancer Institute1996–2001
- Core--Developmental FundsNational Cancer Institute1996–2001
- Uccrc--Cancer Center Support GrantNational Cancer Institute1996–1998
- Phase I Trial Of 5 Ethynyluracil PLUS 5 Fluorouracil For Solid TumorsNational Center For Research Resources1997
- Cancer And LeukemiaNational Cancer Institute1997
- Cancer Center Support GrantNational Cancer Institute1992–1996
- Phase I Trial Of 5-Ethynyluracil PLUS 5-Fluorouracil In Patients With TumorsNational Center For Research Resources1995
- Cancer And Leukemia Group BNational Cancer Institute1993–1994
- Univ Of Chicago CA RES Ctr: Cancer Center Support GrantNational Cancer Institute1993
- Phase I 5-Flurouracil &Leucovorin In Patients With Renal Or Hepatic DysfunctionNational Center For Research Resources1992–1993
- Univ Of Chgo CA RES Ctr--Cancer Center Support GrantNational Cancer Institute1992
- Chemotherapy Committee--Cancer And Leukemia Group BNational Cancer Institute1990–1992
- Univ Of Chgo CA RES Ctr: Cancer Center Support GrantNational Cancer Institute1991
- Clinical &Pharmacological Studies Of IP ChemotherapyNational Center For Research Resources1990–1991
- Cellular Pharmacology Of The Stereoisomers Of LeucovorinNational Cancer Institute1989–1991
- Cellular Pharmacology Of The Stereoisomers Of LeucovorinNational Cancer Institute1989
- Clinical Pharmacologic Studies Of I.P. Chemothx For I.P. CancerNational Center For Research Resources1988–1989
- Intraperitoneal Chemotherapy For Advanced Intraperitoneal &Intrahepatic CancerNational Center For Research Resources1987
- Phase I Study Of Thymidine And Cis-Platin In Patients With Advanced CancerNational Center For Research Resources1985–1986
Professional Memberships
- Fellow
